Lilly posts strong quarterly results, faces challenges ahead
July 22, 2011Sales and Marketing lilly, patent expiry
Lilly edged toward double-digit growth in the second quarter, but looming patent expires threaten this trend. Second quarter revenue grew …
Teva closes one Canadian plant, expands two more
July 22, 2011Manufacturing and Production Canada, Teva
Teva Pharmaceutical has decided to shut down its recently-acquired manufacturing Canadian facility in Montreal, Quebec, having failed to find a …
Merck and Roche extend Victrelis co-promotion deal to Europe
July 22, 2011Sales and Marketing Merck & Co, Roche, Victrelis, hepatitis C
Merck & Co is ramping up efforts to push its new hepatitis C treatment Victrelis to the fore, signing a …
European reprieve for Takeda’s Actos
July 22, 2011Sales and Marketing Actos, diabetes
Takeda’s Actos is likely to remain on the market in Europe but regulators want the diabetes drug to carry stronger …
Digital Pharma: Mobile app regulation
July 21, 2011Medical Communications, Sales and Marketing Digital Phama blog, app, ipad, iphone, mobile
The FDA has proposed new rules for smartphone apps, but says the guidelines will only apply to a small number …
Service Insight: Logical logistics
July 21, 2011Manufacturing and Production Service Insight, manufacturing and production
SERVICE INSIGHTThere is no mistaking that we have been faced with turbulent times over the last year or so and …
FDA approves AstraZeneca’s Brilinta after delay
July 21, 2011Sales and Marketing AstraZeneca, Brilinta, Brilique, antiplatelet
The FDA has finally approved AstraZeneca’s oral blood thinner Brilinta after asking for more information on the drug last year. …
MSI appoints new managing director
July 21, 2011Sales and Marketing appointment, sales and marketing
UK-based pharmaceutical consultancy the MSI Consultancy has appointed Jon Bircher as managing director. He joined MSI in January 2006 from …
Lilly presents data on failed Alzheimer’s candidate
July 21, 2011Research and Development Alzheimer's disease, lilly, research and development news, semagacestat
Lilly has presented a review of data from semagacestat, the Alzheimer’s drug it dropped last year after disappointing results. Phase …
AZ adds new heart warning to Seroquel
July 21, 2011Sales and Marketing Seroquel, antipsychotic
AstraZeneca has added a new heart warning to the packaging on its antipsychotic drug Seroquel at the behest of the …
Merck signs major deal with China’s Simcere
July 21, 2011Sales and Marketing Merck, Simcere, emerging markets
Merck is to establish a joint venture with China’s Simcere focused on serving China’s rapidly expanding health care needs by …
Moorfields Pharmaceuticals and MC2 Biotek Group enter into a collaboration and licence agreement to develop new ophthalmic products
July 20, 2011Manufacturing and Production
Moorfields Pharmaceuticals and MC2 Biotek have signed a collaboration and licence agreement concerning development of novel ophthalmic products addressing unmet …
NICE says no to breast cancer treatment Halaven
July 20, 2011Sales and Marketing Eisai, Halaven, NICE
Eisai’s Halaven has been rejected by NICE in draft guidance for locally advanced or metastatic breast cancer. Halaven (eribulin) is …
Analysis paralysis – how to get the true measure of clinical trials
July 20, 2011Research and Development Les Rose, clinical trials
The great physicist Lord Kelvin famously said: “When you can measure what you are speaking about, and express it in …
Future of AZ-BMS diabetes drug in doubt
July 20, 2011Research and Development, Sales and Marketing AstraZeneca, BMS, dapagliflozin, diabetes, research and development news
A US advisory committee has rejected an investigational compound for type II diabetes sufferers, throwing its future into doubt. Dapagliflozin, …
Hep C drug Victrelis gains EU approval
July 20, 2011Sales and Marketing Incivek, Victrelis, hepatitis C
Merck Sharp & Dohme’s Victrelis, one of two major new hepatitis C drugs, has gained final approval in Europe. Victrelis …
Contract research news in brief
July 20, 2011Research and Development research and development news
M&A abounds in the CRO sector with INC completing its purchase of Kendle, inVentiv snappig up Pharmanet and ICON buying …
Government seeks to salvage pharma pricing reforms
July 19, 2011Sales and Marketing NICE, value-based pricing
The government is pushing ahead with plans to introduce value-based pricing in 2014, despite acknowledging the new system still requires …
Hepatitis C rivals go head to head
July 19, 2011Sales and Marketing Incivek, Incivo, Victrelis, boceprevir, hepatitis C, telaprevir
The field of hepatitis C treatment has two new groundbreaking medicines to treat the condition.Merck’s Victrelis (boceprevir) and Johnson & …
Novartis posts double-digit sales and profit growth
July 19, 2011Sales and Marketing Novartis
Novartis had a strong second quarter of the year, with both sales and profit up on the same period in …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
